Nanjing Vazyme Biotech Co., Ltd. (SHSE:688105) announces a share repurchase program. Under the program, the company will repurchase its A shares for a total of CNY 30 million. The shares will be purchased at a price not exceeding CNY 45 per share.

The repurchased shares will be used for the implementation of ESOP or equity incentive plan. If the company fails to use the shares for the aforementioned purposes within 3 years from the date of completion of program, the unused portion of the repurchased shares shall be cancelled. The program will be funded from company's own funds.

The program will be valid for 12 months.